Using a mutant APC mouse model of colon cancer, we demonstrate that both epithelial and global suppression of TGFβ signaling are associated with a robust inflammatory response in the colon, mediated predominantly by myeloid cells. Here, TGFB1 is linked to malignant colon neoplasm.